Obstructive Sleep Apnoea
Obstructive sleep apnoea/hypopnoea syndrome (OSAHS) is recurrent upper-airway narrowing or closure during sleep, causing sleep fragmentation and intermittent hypoxaemia; diagnosis uses sleep history and objective sleep testing, while treatment is tailored to symptoms, severity, comorbidity, safety risk and treatment adherence.
In a nutshell
OSAHS is recurrent sleep-related upper-airway collapse causing sleep fragmentation, intermittent hypoxaemia and daytime sleepiness or impaired vigilance. Suspect it from snoring, witnessed apnoeas, choking, unrefreshing sleep, morning headache, nocturia or unexplained fatigue; confirm with objective sleep testing. Treat with lifestyle measures plus CPAP when indicated, and address driving risk, adherence and OHS separately.
Classic presentation
Habitual snoring with witnessed apnoeas or choking, unrefreshing sleep and daytime sleepiness, often with obesity or treatment-resistant hypertension.
Key points
- The pharynx collapses when sleep-related loss of dilator-muscle tone meets anatomical narrowing; repeated arousals reopen it but fragment sleep.
- Use the Epworth Sleepiness Scale in assessment but not alone to decide referral; obtain collateral history and assess driving/vigilance risk.
- Offer home respiratory polygraphy as the first-line objective test. AHI severity: mild 5 to <15, moderate 15 to <30, severe 30 or more events/hour.
- Fast-track vocational/vigilance-critical workers, unstable cardiovascular disease, pregnancy, urgent major-surgery assessment and non-arteritic anterior ischaemic optic neuropathy.
- Offer fixed-level CPAP for moderate or severe OSAHS; for symptomatic mild OSAHS offer CPAP with priority factors or after lifestyle advice is unsuccessful/inappropriate.
- A mandibular advancement splint is a selective alternative when CPAP is declined or not tolerated; check age, dentition and periodontal health.
- OHS requires obesity, awake hypercapnia and sleep-related breathing abnormality; severe OHS-related OSAHS starts with CPAP, while persistent hypercapnia or non-severe OSAHS may require NIV.
- Anyone with sleepiness that may impair driving must stop driving; moderate/severe OSAHS with excessive sleepiness must be notified to DVLA, and mild or suspected disease must be notified if control is not achieved within 3 months.
First-line investigation
Sleep and collateral history, Epworth/STOP-Bang assessment and home respiratory polygraphy; add blood gases and carbon-dioxide monitoring when OHS or overlap syndrome is suspected.
Management
Protect against sleepiness-related harm
Confirm OSAHS and identify OHS
Change risk factors and support tolerance
Choose pressure or oral treatment by phenotype
Exam traps
- A low Epworth score does not exclude OSAHS and should not override witnessed apnoeas, comorbidity or safety risk.
- Oximetry alone may be insufficient, especially in heart failure or chronic lung disease; use respiratory polygraphy or polysomnography when indicated.
- Do not treat OHS as uncomplicated OSAHS: confirm awake hypercapnia and consider NIV if CPAP does not correct symptoms, hypercapnia or respiratory indices.
- A mandibular advancement splint requires suitable dental and periodontal health; positional devices are unlikely to treat severe OSAHS.
- Excessive sleepiness and driving restrictions are safety issues even before a diagnosis is confirmed; apply the current DVLA rule, not a memorised threshold.
Illustrations
Key sources
- NICE NG202: Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s (NICE guideline NG202; published 20 August 2021, with current recommendations for OSAHS, OHS and COPD–OSAHS overlap syndrome.)Updated 1 Mar 2025
- NICE CKS: Obstructive sleep apnoea syndrome (NICE Clinical Knowledge Summary for primary-care recognition and management; access may require NHS login.)
- NICE TA139: Continuous positive airway pressure for obstructive sleep apnoea/hypopnoea syndrome (NICE technology appraisal TA139; updated 20 August 2021 and cross-referenced by NG202 for moderate and severe symptomatic OSAHS.)Updated 20 Aug 2021
- DVLA: Miscellaneous conditions—assessing fitness to drive, excessive sleepiness including OSA (UK government/DVLA guidance last updated 7 November 2025; includes Group 1 and Group 2 restrictions and notification requirements.)Updated 7 Nov 2025
- BNF online (Current UK prescribing information for sedatives, nasal corticosteroids, antihistamines and ventilatory-support medicines; check current entries before prescribing.)
- NICE HTG735: Home-testing devices for diagnosing obstructive sleep apnoea hypopnoea syndrome (NICE HealthTech guidance HTG735; published 19 December 2024.)Updated 19 Dec 2024
This page is exam revision material, not medical advice, and must not be used for patient care. Always check drug doses against the BNF and current guidance. Full disclaimer.

